NCT06138106 Developing a Nutritional Supplement to Increase Collagen Synthesis in People
| NCT ID | NCT06138106 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Davis |
| Condition | Dietary Supplements |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2023-11-21 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2023-11-21 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to test whether a natural product supplement can potentiate the increase in collagen synthesis following the ingestion of collagen protein. The investigators have developed a model of natural (GRAS certified) products that stimulate collagen synthesis, in vitro. The investigators will determine whether the natural product supplement can potentiate the collagen synthetic response to the ingestion of collagen protein. Basal and fed serum will be isolated and these samples will be used to treat human engineered ligaments.
Eligibility Criteria
Inclusion Criteria: * Young healthy adults (18-30 y) Exclusion Criteria: * Pregnancy * Smoking * Receiving any medication that may interfere with the study outcomes
Contact & Investigator
Keith Baar, PhD
PRINCIPAL INVESTIGATOR
University of California, Davis
Frequently Asked Questions
Who can join the NCT06138106 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Dietary Supplements. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06138106 currently recruiting?
Yes, NCT06138106 is actively recruiting participants. Contact the research team at kpaulussen@ucdavis.edu for enrollment information.
Where is the NCT06138106 trial being conducted?
This trial is being conducted at Davis, United States.
Who is sponsoring the NCT06138106 clinical trial?
NCT06138106 is sponsored by University of California, Davis. The principal investigator is Keith Baar, PhD at University of California, Davis. The trial plans to enroll 20 participants.